Free Trial

Anika Therapeutics (ANIK) Stock Forecast & Price Target

-0.37 (-1.35%)
(As of 07/12/2024 ET)

Anika Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

12.42% Upside
High Forecast$37.00
Average Forecast$30.50
Low Forecast$24.00
TypeCurrent Forecast
7/15/23 to 7/14/24
1 Month Ago
6/15/23 to 6/14/24
3 Months Ago
4/16/23 to 4/15/24
1 Year Ago
7/15/22 to 7/15/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$30.50$30.50$29.50$29.50
Forecasted Upside12.42% Upside19.00% Upside16.74% Upside6.51% Upside
Get Anika Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter.

ANIK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ANIK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Anika Therapeutics Stock vs. The Competition

TypeAnika TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside12.42% Upside994.16% Upside9.20% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$24.00 ➝ $24.00-5.85%
5/9/2024Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$37.00 ➝ $37.00+43.58%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:47 AM ET.

ANIK Forecast - Frequently Asked Questions

What is Anika Therapeutics' forecast for 2024?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Anika Therapeutics is $30.50, with a high forecast of $37.00 and a low forecast of $24.00.

Should I buy or sell Anika Therapeutics stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Anika Therapeutics in the last twelve months. There is currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ANIK shares.

Does Anika Therapeutics's stock price have much upside?

According to analysts, Anika Therapeutics's stock has a predicted upside of 19.00% based on their 12-month stock forecasts.

What analysts cover Anika Therapeutics?

Anika Therapeutics has been rated by research analysts at Barrington Research, and Stephens in the past 90 days.

Do Wall Street analysts like Anika Therapeutics more than its competitors?

Analysts like Anika Therapeutics less than other "medical" companies. The consensus rating score for Anika Therapeutics is 2.50 while the average consensus rating score for "medical" companies is 2.71. Learn more on how ANIK compares to other companies.

This page (NASDAQ:ANIK) was last updated on 7/14/2024 by Staff

From Our Partners